2nd European Cancer Patient Seminar

June 09, 2003

People with cancer, doctors and politicians are joining forces in Edinburgh on June 20 and 21 to improve the care of patients with cancer. At a special seminar organised by the European Society for Medical Oncology, patients and oncologists will aim to create a genuine patient-physician partnership that spans Europe.

Supported by various European cancer groups, the seminar will reflect the true spirit of partnership:

  • Patients have collaborated with oncologists in planning an extremely interesting programme,
  • Lectures will be given by both patients and physicians,
  • Patients and oncologists will meet for an interactive joint session, where both sides will express and explain their positions on current issues in oncology.

    Cancer patients and their carers are invited to join us. You can tell us what patients and their families want from their ideal cancer doctor. Doctors will tell you what they expect from patients. Together we can discuss what can be done to improve communication - and ultimately improve healthcare services for cancer patients.

    If you are interested in attending, contact : ESMO Congress Secretariat
    Tel. 41-91-973-1919, alessia@esmo.org / chatrina@esmo.org
    The registration fee of EUR 30.- includes:

  • Participation in the ESMO Patient Seminar
  • Proceedings
  • Lunch and coffee breaks during the Seminar
  • If interested, attendance of the ESMO Summer Educational Conference

    Please note that the ESMO Congress Secretariat should be contacted if the registration fee presents a problem.
    For more information about the seminar, please visit: http://www.esmo.org/SummerConference/patientSeminar.html
    Press enquiries:
    Elaine Snell, ESMO Press Office (UK)
    Tel. 44-207-738-0424, elaine.snell@which.net
    Gracemarie Bricalli, ESMO Media Coordinator (Switzerland)
    Tel. 41-91-973-1911, gracemarie@esmo.org

    European Society for Medical Oncology

    Related Cancer Articles from Brightsurf:

    New blood cancer treatment works by selectively interfering with cancer cell signalling
    University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

    UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
    A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

    Breast cancer treatment costs highest among young women with metastic cancer
    In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

    Cancer mortality continues steady decline, driven by progress against lung cancer
    The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

    Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
    Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

    Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
    The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

    Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
    Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

    More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
    An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

    New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
    Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

    American Cancer Society outlines blueprint for cancer control in the 21st century
    The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

    Read More: Cancer News and Cancer Current Events
  • Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.